Harmon.Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: flat-price compounded semaglutide or tirzepatide with free shipping and a low first month
Harmon.Health scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $149/mo ongoing
Tirzepatide
then $225/mo ongoing
Price checked on Harmon.Health’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Harmon.Health is a telehealth service that carries the Harmon name once used by health and beauty stores, offering compounded semaglutide and tirzepatide with one price at every dose that covers the visit, medication, supplies and shipping. Semaglutide is $149 and tirzepatide $225 month to month, and a Black Friday deal cuts the first month of either to $99. It also offers microdose and dissolving-tablet GLP-1s, the Wegovy pill, menopause care and hair treatments.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Harmon.Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
from $149/mo (after intro offer) · no insurance needed
Harmon.Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo (after intro offer) ($99 first month)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Harmon.Health
Each dimension is scored algorithmically from Harmon.Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $149/mo (after intro offer), Harmon.Health runs about 17% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $99.
Effectiveness25%
7.7/10Harmon.Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.9/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.6/10Harmon.Health's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.4/10Harmon.Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Harmon.Health review
Last checked November 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$233/mo across 4 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Harmon.Health
We walked Harmon.Health’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Choose a medication, a monthly or 3-month plan and a starting dose on the product page, with the price shown
- 2Start your journey opens a separate intake site that lists the steps: choose a treatment area, create an account, complete a health assessment
- 3Harmon says a licensed physician reviews your profile, typically within 24 hours, with no video call
- 4If approved, the prescription ships from a partner pharmacy, with most orders arriving in 2 to 5 business days
- The product pages show the regular price, the Black Friday price and the price for each dose before you start
- The 3-month plan's regular price is higher per month than the monthly plan, though the FAQ calls it about 15% less per month
- The guarantee's full terms are said to be provided at checkout
- The site also invites visitors to buy shares in its parent company through a crowdfunding offering
Harmon.Health customer support
- Hello@harmon.health
GLP-1 medications Harmon.Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$149 a month at every dose, covering the visit, medication, supplies and shipping. Black Friday deal: $99 for the first month.
$499 every 3 months (about $166 a month). Black Friday deal: $200 for 3 months.
$225 a month at every dose, covering the visit, medication, supplies and shipping. Black Friday deal: $99 for the first month.
$699 every 3 months (about $233 a month). Black Friday deal: $200 for 3 months.
Ready to get started?
Plans and promotions change often, so check Harmon.Health's current pricing and active discounts before you decide.
What we like
- Prices are published before you start, with one price at every dose
- The monthly price covers the visit, medication, supplies and free shipping, with no membership fee
- Black Friday deal: $99 for the first month of semaglutide or tirzepatide
- You pay only if a provider prescribes treatment
- 90-day results guarantee refunds the program fee if you follow the plan and see no progress
- Names its partner provider group, Wasef Health
Watch-outs
- The Terms of Service, Telehealth Consent and HIPAA Notice links go nowhere, so the full terms are not available to read before checkout
- Outside the Black Friday deal, the 3-month plan costs more per month than paying monthly
- The legal entity behind the service is not named on the site
- The pharmacies that fill prescriptions are not named
- The LegitScript seal is an image hosted on its own site
- No phone number or support email on the contact page; help runs through the patient portal
- Tirzepatide is $225 a month after the first-month deal
Is Harmon.Health worth it?
What Harmon.Health is selling, in one line, is flat-price compounded semaglutide or tirzepatide with free shipping and a low first month. New patients start at $99/month for the first month, but the price steps up to $149/month once that window ends, so treat the headline number as an intro offer, not the standing rate. Its standout is a needle-free oral option for people who would rather not inject.
Beyond the medication itself, Harmon.Health charges the same price at every dose. It also charges no membership fee and offers a microdosing option.
How much Harmon.Health costs
- Compounded semaglutide starts at $99 for the first month, then $149/month after that, for that option.
- Compounded tirzepatide starts at $99 for the first month, then $225/month after that, if you go that route.
Because Harmon.Health's headline figure is listed as “after intro offer”, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Harmon.Health with the month-to-month prices of the alternatives below instead.
PlexusDx (about $149/month) is one of the closest alternatives to weigh Harmon.Health against.
Medications: what Harmon.Health prescribes
Harmon.Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Harmon.Health's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Harmon.Health is best for, and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Harmon.Health is one of the easiest ways to start a GLP-1 cheaply, as long as you go in knowing that the $99 intro price steps up to $149/month once the first month is behind you. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in. To see Harmon.Health against the wider field, use the full list of semaglutide providers we rank; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Harmon.Health scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Harmon.Health?
From $149/mo (after intro offer). See current pricing and start your free consultation.
Harmon.Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Harmon.Health vs…
Harmon.Health scores7.0/10
Side-by-side pricing, medications and scores. Pick a matchup.
Harmon.Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

Harmon.Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Harmon.Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Harmon.Health's current pricing
Plans from $149/mo (after intro offer). Start your free consultation to check eligibility and today's price.